Related by context. All words. (Click for frequent words.) 70 Inventory BPI 69 Visual Analogue Scale VAS 69 Brief Psychiatric 69 WOMAC pain 69 Visual Analog Scale 69 ADCS CGIC 69 Global Impression CGI 69 Index CDAI 68 Montgomery Asberg Depression 67 Brief Pain 67 Visual Analog 66 Montgomery Åsberg Depression 66 Primary endpoints 66 non menstrual pelvic 66 left ventricular diastolic 66 erythrocyte sedimentation rate 66 Health Assessment Questionnaire 66 Cardiorespiratory fitness 66 NIH CPSI 65 ADAS cog 65 nasal symptom 65 Crohn Disease Activity 65 Severity Index PASI 65 YMRS 65 function subscales 65 subscores 65 Alzheimer Disease Assessment 65 Score DAS 65 BMI z 65 Skin sterol 65 DAS# CRP 65 SGRQ 65 NYHA functional class 64 Rating Scale MADRS 64 SF #v# 64 Rating Scale UPDRS 64 WOMAC 64 dyspnoea 64 EQ 5D 64 UPDRS 64 Ashworth Scale 64 aspartate aminotransferase AST 64 FIQ 64 bronchial hyperresponsiveness 63 oxycodone CR 63 International Prostate Symptom 63 ADAS Cog 63 Symptom severity 63 PLX STROKE targeting 63 State Examination MMSE 63 Glasgow Coma Scale 63 HAQ DI 63 Disease Activity 63 DAS# scores 63 IBDQ 63 Visual Analogue Scale 63 cortical atrophy 63 Negative Symptoms 63 urine albumin 63 APACHE II 63 Functional Outcomes 63 Dyspnea 63 electrophysiologic 63 Psoriasis Area 63 intraobserver 63 Severity MSCS score 63 nerve conduction velocity 63 Scale PANSS 63 Pain Intensity 63 Unified Parkinson Disease 63 artery stenosis 62 serum phosphorous 62 Neuropsychiatric Inventory 62 NIS LL 62 clinically meaningful improvement 62 plus methotrexate 62 OSAHS 62 MMSE score 62 interobserver 62 PANSS 62 NIHSS 62 hemodynamic measurements 62 demonstrated clinically meaningful 62 exploratory endpoints 62 depressive symptom 62 somatostatin analog 62 subscale scores 62 Thrombolysis 62 PANSS total 62 CNS LS 62 diastolic blood pressures 62 prespecified secondary 62 autonomic dysfunction 62 vitreous floaters 62 subscales 62 affective psychosis 62 euthymic patients 62 apnea hypopnea index 61 Negative Syndrome 61 morphometric vertebral fractures 61 receiving XGEVA 61 mcg QD 61 baseline PASI 61 MADRS score 61 Secondary endpoints included 61 abdominal pain abdominal discomfort 61 Tasigna prolongs 61 symptom severity 61 PLMs 61 CPAP adherence 61 Tumor Response 61 WOMAC scores 61 eNO 61 coronary stenosis 61 PCWP 61 EORTC QLQ C# 61 UPDRS motor 61 Index WOMAC 61 Ocular Surface Disease 61 anthropometric measures 61 prospectively stratified 61 Score IPSS 61 HAM D# 61 paresthesias 61 HADS 61 tissue oxygenation 61 hepatic lesions 61 8mg/kg 61 Oswestry Disability Index 61 calculated creatinine clearance 61 Mean Symptom Complex 61 cerebral oxygenation 61 HDRS 61 Physical Component 61 HOMA IR 61 Hamilton Anxiety Scale 61 Endothelial function 61 Scale EDSS 61 akinesia 61 Efficacy endpoints 61 #q# deletion syndrome 61 ecchymosis 61 waist circumference WC 61 echocardiographic parameters 61 zonisamide SR 61 urinary N telopeptide 61 exhaled NO 60 clinically meaningful improvements 60 mg BID dose 60 DAS# [002] 60 subjective sleepiness 60 Seattle Angina Questionnaire 60 hematological parameters 60 extrapyramidal symptoms 60 CIMZIA TM certolizumab pegol 60 Physical Function 60 electroencephalographic 60 postoperative AF 60 overnight polysomnography 60 Secondary efficacy endpoints 60 Preoperatively 60 poststroke 60 MoxDuo TM IR 60 LDL HDL 60 erection hardness 60 confirmed CCyR 60 Cystic Fibrosis Questionnaire Revised 60 INVEGA ® 60 -#.# mg dL [001] 60 arterial oxygen saturation 60 Beck Anxiety Inventory 60 dactylitis 60 DLQI 60 Comorbidity 60 Preoperative 60 intraclass correlation coefficients 60 Coronary artery calcium 60 WOMAC TM 60 Histologic 60 Ejection Fraction 60 Pain Rating Scale 60 clinically meaningful reductions 60 headache abdominal pain 60 SELENA SLEDAI 60 Meta analyzes 60 PSQI 60 nonvertebral fracture 60 HRQL 60 hyperreflexia 60 intravascular hemolysis 60 dyssynchrony 60 subscore 60 budesonide pMDI 60 nasopharyngitis headache 60 Postoperative 60 desvenlafaxine succinate 60 Scale Cognitive Subscale 60 hemodynamic parameters 60 secondary efficacy endpoint 60 nausea photophobia 60 MADRS 60 enthesitis 60 ASIA Impairment 60 Distress Scale 60 confidence intervals CIs 60 logistic regression analysis 60 polysomnography PSG 60 Pharmacokinetic parameters 60 CDAI 60 Expanded Disability Status 60 Persistent Sleep 60 Score TOS 60 methotrexate monotherapy 59 symptomatic VTE 59 femoral neck BMD 59 affective psychoses 59 cognitive affective 59 psychometric properties 59 quantitative coronary angiography 59 vasomotor 59 neurosensory 59 actigraphy 59 GERD symptom 59 Claudication 59 prednisone prednisolone plus 59 Epworth Sleepiness Scale 59 premorbid 59 left ventricular systolic 59 spirometric 59 HbA1C levels 59 FDG-PET/CT 59 Left Ventricular Ejection Fraction 59 unresectable HCC 59 Cholinesterase Inhibitors 59 Main Outcome Measures 59 CTEPH 59 BPH symptom 59 Lower Limb 59 glycosylated hemoglobin HbA1c 59 postprocedure 59 attain statistical significance 59 clinicopathological features 59 Y BOCS 59 biopsy Gleason 59 interobserver reliability 59 submaximal 59 patellofemoral pain syndrome 59 PASI scores 59 maximal treadmill 59 Wechsler Adult 59 Cardiotoxicity 59 polysomnographic 59 glycosylated hemoglobin levels 59 tertiles 59 ACTEMRA TM 59 Nonspecific 59 System IPSS 59 detrusor overactivity 59 CDAI score 59 Depressive Symptoms 59 Functional Assessment 59 CHADS2 59 pulmonary capillary wedge 59 moderate renal impairment 59 PSA nadir 59 somatic symptom 59 conditional logistic regression 59 abdominal adiposity 59 tapentadol IR 59 Scale cognitive subscale 59 NNT = 59 hip BMD 59 relapsed MM 59 gait disturbances 59 Postoperatively 59 LV dysfunction 59 VaD 59 PANSS Positive 59 #mg/day [001] 59 primary aldosteronism 59 covariate 59 HIV HCV coinfected 59 OSDI 59 deCODE AF TM 59 serum BDNF 59 unfractionated heparin UFH 59 tic severity 59 visceral adiposity 59 Vascular dementia 59 Rating Scale BPRS 59 Hypertrophy 59 albumin excretion rate 59 intima media thickness IMT 59 abdominal circumference 59 Non inferiority 59 CORE OM 59 hemoglobin A1c levels 59 transaminase elevations 59 comorbid anxiety 59 preoperative intraoperative 59 serum aminotransferase levels 59 haematologic 58 diabetic peripheral neuropathic DPN 58 cough dyspnea 58 nausea dizziness vomiting 58 CSF biomarkers 58 P = .# 58 State Exam MMSE 58 ADCS ADL 58 serum triglycerides 58 cardiac autonomic 58 asthenia fatigue 58 #mm Hg 58 SGOT 58 Likert pain 58 PsA 58 Coronary artery calcification 58 diastolic pressures 58 Diastolic 58 linaclotide treated 58 cerebral perfusion 58 comorbid disorders 58 Injury Severity Score 58 nonvertebral 58 variant angina 58 Outcome Measures 58 postintervention 58 HRQoL 58 elevated ALT 58 dose pravastatin 58 mcg BID 58 fatigue abdominal pain 58 NYHA 58 cTnT levels 58 CLBP 58 impaired glucose metabolism 58 LV ejection fraction 58 Neuropsychiatric Inventory NPI 58 ratio WHR 58 hyperintensities 58 KOOS 58 tremors slowness 58 hyperlipidaemia 58 hyperphenylalaninemia HPA due 58 cardiorespiratory endurance 58 aMCI precursor 58 carotid stenosis 58 intracranial atherosclerosis 58 NeuroMove TM 58 Stroke Scale 58 Cystatin C 58 AST ALT 58 Fracture Risk 58 cognitive domains 58 NMES 58 achieved statistical significance 58 Treatment Outcome 58 methacholine challenge 58 subsyndromal 58 mmHg diastolic 58 intima media thickness 58 transcranial Doppler ultrasound 58 orthostatic 58 Mental Component 58 salmeterol fluticasone 58 IPSS 58 semiquantitative 58 Hyperlipidemia 58 lymphocyte count 58 ACR# ACR# 58 Mania Rating Scale 58 salmeterol fluticasone propionate 58 tapentadol ER 58 hematopoietic cancers 58 EEG abnormalities 58 pyridostigmine 58 trials RCTs 58 angioplasty stenting 58 extracranial 58 alanine aminotransferase ALT 58 acetabular dysplasia 58 idiopathic Parkinson disease 58 proton MR spectroscopy 58 interobserver agreement 58 TNSS 58 UPDRS Part III 58 bone marrow reticulin deposition 58 daytime somnolence 58 SBM frequency 58 MMSE 58 colorectal adenoma 58 fasting plasma glucose FPG 58 Ischemic 58 oral anticoagulation 58 hyperalgesia 58 FDG PET imaging 58 activated partial thromboplastin 58 headache nasopharyngitis 58 TEAEs 58 #.#mmHg 58 Spirometry 58 adjunctive ABILIFY 58 primidone 58 liver histology 58 parkinsonian 58 mean ± SEM 58 lopinavir r arm 58 peak VO2 58 multivariate analyzes 58 generalized epilepsy 58 obstructive sleep 58 exhaled nitric oxide 58 opioid naïve 58 moderate hepatic impairment 58 postoperative complication 58 drotrecogin alfa activated 58 Warfarin Coumadin 58 Spinal manipulation 58 intraclass correlation coefficient 58 Myocardial Infarction TIMI 58 Lewy bodies DLB 58 BENICAR HCT 58 chronic thromboembolic pulmonary 58 bleeding pallor 58 HAMD 58 Baseline characteristics 58 atherogenic dyslipidemia 58 anemia hemoglobin 58 pain subscale 58 EMBLEM TM 58 Apidra ® 57 subthreshold depression 57 Geriatric Depression 57 fasting insulin 57 multiple linear regression 57 meta regression 57 oxycodone IR 57 obstructive CAD 57 Cronbach alpha 57 artery elasticity 57 analgesic medications 57 schizophrenia schizoaffective disorder 57 nausea emesis 57 Naive Patients 57 histologic subtype 57 contrast echocardiography 57 Ishak fibrosis score 57 nonfasting triglyceride levels 57 IBS C 57 pulmonary arterial 57 pain catastrophizing 57 SGPT 57 -#.# log# copies mL 57 tipranavir r 57 quantitative computed tomography 57 underwent coronary angiography 57 -#.# ± [002] 57 dyspareunia 57 titrated glipizide 57 MMSE scores 57 Global Impression 57 convergent validity 57 neurocognitive function 57 mRS 57 lumbar disk herniation 57 gadobutrol 57 XIENCE V PROMUS Stent 57 elevated IOP 57 STRATEGY FOR AN OPEN 57 Clinician Administered PTSD 57 mild renal impairment 57 preoperative PSA 57 temporoparietal 57 subclinical atherosclerosis 57 Viral load 57 Prospective Randomized 57 NSTE ACS 57 diffusion tensor 57 achieved ACR# 57 serum PTH 57 analgesic efficacy 57 BPS IC 57 gastric cardia 57 palpitations shortness 57 Operative mortality 57 placebo p = 57 bioavailable testosterone 57 carotid IMT 57 chronic diarrhea abdominal 57 infliximab monotherapy 57 angiographically 57 STRIDE PD 57 Atomoxetine 57 IIEF 57 TURBT 57 NPRS 57 pharmacodynamic parameters 57 Acute Physiology 57 Orthostatic Hypotension 57 Arterial stiffness 57 Oral Fingolimod 57 serum urate levels 57 reduce serum phosphate 57 NSAID associated 57 knee osteoarthritis OA 57 Sleep disturbances 57 Depressive symptoms 57 β blockers 57 Descriptive statistics 57 leucopenia 57 Likert scale 57 mm Hg diastolic 57 periprocedural 57 multivariate Cox 57 ITU algorithms PAMS 57 LDL triglycerides 57 EDSS score 57 preoperatively 57 resynchronization therapy 57 hippocampal atrophy 57 dose Iluvien 57 CI -#.# 57 plasma leptin 57 carotid artery intima media 57 metabolic syndrome MetS 57 MDCT angiography 57 Univariate 57 tolterodine ER 57 atherothrombotic disease 57 Secondary endpoints 57 fractional anisotropy 57 gastroduodenal 57 baseline HbA1c 57 plasma creatinine 57 bone erosions 57 myocardial viability 57 constipation predominant IBS 57 Haptoglobin 57 HER2 expression 57 Echocardiographic 57 Arterial Hypertension 57 phonophobia 57 CFQ R 57 timepoints 57 salivary cortisol 57 C Reactive Protein 57 psychosocial variables 57 Comorbidities 57 oncologic outcomes 57 lumbar spine bone 57 Ventricular Arrhythmias 57 limiting generalizability 57 nontraumatic 57 FFR measurements 57 RoACTEMRA 57 azilsartan medoxomil 57 Uncontrolled hypertension 57 Scale EDSS score 57 Obstructive sleep apnea OSA 57 prospective multicenter study 57 duplex ultrasonography 57 sensitivity specificity 57 Index CDAI score 57 CC genotype 57 Erythropoietic therapies may 57 somnolence dizziness 57 4mg/kg 57 multivariate adjustment 57 fructosamine 57 Angiographic 57 Apolipoprotein B 57 vestibular rehabilitation 57 plasma folate 57 lesional 57 BARACLUDE r 57 Diabetic neuropathy 57 multiple logistic regression 57 hemodynamically significant 57 fatigue nausea vomiting 57 patients undergoing CABG 57 Arrhythmias 57 Endarterectomy 57 daytime alertness 57 nausea vomiting headache 57 MSLT 57 FFNS 57 Stroke Scale NIHSS 57 comorbid depression 57 adjunctive placebo 57 Levels Linked 57 Ankylosing Spondylitis 57 Ischemic Stroke 57 interrater reliability 57 ALSFRS R 57 hypometabolism 57 diarrhea dyspepsia 57 Main Outcome Measure 57 Electromyography 56 T2DM 56 nonfatal myocardial infarction MI 56 Ankle Brachial Index 56 DAS# remission 56 carcinomatosis 56 gastro esophageal reflux 56 sub maximal 56 somatic symptoms 56 chills fever headache 56 ejection fractions 56 spontaneous bowel movements 56 acute postoperative 56 antiretroviral naïve 56 oxygen saturation SpO2 56 hemiparesis 56 psoriatic arthritis PsA 56 non vertebral fractures 56 NWEA MAP 56 baseline serum creatinine 56 posttreatment 56 bacterial prostatitis 56 surgically induced 56 lumbar spine BMD 56 Neuropsychological Status 56 cardiac magnetic resonance 56 SIMPADICO 56 Generalized Anxiety Disorder 56 lumbosacral spine 56 PLMS 56 Desvenlafaxine Succinate 56 6MWD 56 Heart Rate Variability 56 fluticasone salmeterol 56 varus valgus 56 Castration Resistant Prostate Cancer 56 odds ratios ORs 56 psychiatric comorbidities 56 rosuvastatin #mg 56 acute subacute 56 DEXA scan 56 CP CPPS 56 RAPAFLO R 56 creatine kinase MB 56 microbiologically evaluable 56 hyperarousal 56 Status Scale EDSS 56 varus deformity 56 APTIVUS R 56 ALT elevations 56 improves glycemic 56 Chronic Illness Therapy 56 hyperuricaemia 56 psychophysiological 56 Electroencephalography 56 venous thromboembolic disease 56 Doppler echocardiography 56 logistic regression analyzes 56 Relapsing Multiple Sclerosis 56 Kellgren Lawrence 56 Computerized tomography 56 posttest 56 nadolol 56 p = #.# [003] 56 T2 lesions 56 BPH Symptom Score 56 N telopeptide 56 pelvic lymphadenectomy 56 dizziness somnolence 56 hemoglobin A1c HbA1c 56 CYP#D# inhibitor 56 serum cortisol 56 lipid lowering agents 56 coronary calcification 56 exertional chest 56 urinary albumin 56 QoL 56 mitoxantrone plus 56 Histological 56 ARB telmisartan 56 transcranial Doppler 56 posterior cingulate 56 clinicopathological 56 unstable angina pectoris 56 FluCAM arm 56 XIENCE V demonstrated 56 apolipoprotein B 56 Zometa hazard 56 CK MB 56 β blocker 56 tissue oxygen saturation 56 SRBD 56 Coronary Artery Bypass Graft 56 chronic prostatitis chronic 56 glomerular filtration 56 radiotherapy RT 56 anemia thrombocytopenia 56 subtests 56 intracerebral haemorrhage 56 weekly subcutaneous injections 56 overactive bladder symptoms 56 hepatic enzyme 56 tumor histology 56 Endothelial dysfunction 56 gadolinium enhanced 56 aplindore 56 carotid artery blockage 56 CIMZIA R 56 Pelvic Organ Prolapse 56 neutropenia fatigue 56 histological subtype 56 multicenter multinational 56 Scheuermann kyphosis 56 Daytime sleepiness 56 hemodynamic variables 56 asthenia weakness 56 glucose insulin 56 dermatologic reactions 56 Thiazolidinediones 56 neuritic 56 emotional lability 56 ST Segment Elevation 56 Electrophysiological 56 hepatic enzymes 56 Polysomnography 56 epoetin alpha 56 aromatase inhibitor therapy 56 IELT 56 univariate 56 preintervention 56 pretest probability 56 nonischemic 56 myocardial perfusion 56 stratifying patients 56 mineral density 56 Coronary artery bypass grafting 56 MCyR 56 nausea diarrhea fatigue 56 microvessel 56 polysomnography 56 Bonferroni correction 56 baseline LDH 56 #.#/#.# mmHg [001] 56 serum lipid levels 56 multivessel disease 56 fatigability 56 hypercholesterolaemia 56 SPECT MPI 56 IRLS 56 stage IIIb IV 56 diaphoresis 56 erythema nodosum 56 serum leptin 56 Hemiplegia 56 lactate dehydrogenase LDH 56 troponin T 56 conjunctival injection 56 myocardial function 56 CIMZIA ™ 56 recurrent DVT 56 postinjury 56 PHPT 56 ALS Functional 56 included exfoliative dermatitis 56 HRQOL 56 plus MTX 56 prolactin elevation 56 esophageal carcinoma 56 arterial elasticity 56 preoperative diagnosis 56 bronchoalveolar lavage BAL 56 oral FTY# 56 arterial thromboembolic events 56 waist girth 56 AGILECT ® 56 neutropaenia 56 arterial calcification 56 RECIST Response Evaluation Criteria 56 mineral density BMD 56 Peripheral arterial disease 56 Transurethral 56 PRADAXA #mg 56 bupropion SR 56 urodynamic 56 organ perfusion 56 QTc prolongation 56 Chronic pelvic 56 hematologic parameters 56 #F FDG PET 56 thromboembolic complications 56 abacavir lamivudine 56 rCBF 56 #mmHg [001] 56 thyrotropin levels 56 Description Enhance 56 SSRI citalopram 56 Sleep Disturbances 56 aldosterone antagonist 56 intravaginal ejaculatory latency 56 nondiabetic patients 56 creatinine clearance 56 headaches dizziness disorientation nausea 56 osteopenic 56 Insulin sensitivity 56 oral antidiabetic medication 56 intraventricular 56 cTnT 56 mg XP# 56 Capacity FVC 56 intratympanic 56 electromyogram 56 SSRI SNRI 56 WAIS III 56 QTc intervals 56 irbesartan 56 neutropenia thrombocytopenia 56 nausea somnolence 56 plasma homocysteine 56 #OHD 56 oral hypoglycemic agent 56 retest reliability 56 constipation OIC 56 International Prognostic Scoring 56 Hypotension 56 Coronary angiography 56 completely resected 56 #.#ng/ml 56 serologically active patients 56 antiarrhythmic drug 56 Helps Relieve 56 unstable angina chest 56 neurobehavioral functioning 56 Interrater reliability 56 Fasting blood glucose 56 constipation nausea 56 Prostate specific antigen 56 hemoglobin Hb 56 hypertension diabetes mellitus 56 systolic diastolic 56 Systemic Sclerosis 56 psychosocial functioning 56 depressive symptomatology 56 CYT# potent vascular disrupting 56 albumin excretion 56 biventricular pacing 56 Secondary endpoints include 56 DPNP 56 Ankylosing spondylitis 56 statistically significant efficacy 56 lowest tertile 56 SYNTAX 56 rhinoconjunctivitis 56 brachial artery flow 55 Multivariate analysis revealed 55 Methotrexate MTX 55 Scale CNS 55 Subgroup analyzes 55 death reinfarction 55 cartilage lesions 55 statistically significant p = 55 Electrocardiography 55 F FDG PET 55 Index FSFI 55 psychopathological symptoms 55 dose atorvastatin 55 transabdominal 55 atrioventricular block 55 systolic function 55 logistic regression model 55 treated nonsurgically 55 arteriolar 55 Hypertriglyceridemia 55 hypoperfusion 55 PESQ 55 Edinburgh Postnatal Depression 55 rimonabant #mg/day 55 cardiac repolarization 55 extrapyramidal side 55 Chronic Heart Failure 55 MetS 55 rheumatological 55 perceptual reasoning 55 BILAG 55 Vertebral Fractures 55 QIDS SR 55 ADHD RS 55 Prognostic significance 55 episodic migraine 55 flexion extension 55 QRS width 55 Left Ventricular 55 postural instability 55 procedural sedation 55 worsening thrombocytopenia 55 oral rivaroxaban 55 nonfatal MI 55 3mg/kg 55 percutaneous vertebroplasty 55 thetreatment 55 TMS Therapy 55 alexithymia 55 clinico pathological 55 hepatic renal 55 Teriflunomide 55 hyperhomocysteinemia 55 cardio respiratory fitness 55 atorvastatin #mg 55 BEXXAR Therapeutic Regimen 55 rheumatoid factor 55 arthralgias 55 alfuzosin 55 medial compartment 55 cystoscopic 55 ACE Inhibitors 55 Kinesia 55 fatigue headache nausea 55 orthostatic blood 55 teriflunomide 55 vascular cognitive impairment 55 zolmitriptan 55 atrial pacing 55 RECORD1 55 APTIVUS r 55 Univariate analysis 55 mitral annular 55 Myelosuppression 55 nasal obstruction 55 hyper IgE syndrome 55 LUTS 55 amnestic MCI 55 ANCOVA 55 #.#mg/dL 55 Hemodynamic 55 locomotor activity 55 #OHD levels 55 CYP#A# CYP#D# 55 Symptom Severity 55 allodynia 55 Natalizumab 55 Multidetector CT 55 ACE Inhibitor 55 capillary density 55 myelodysplastic myeloproliferative diseases 55 unpaired t 55 chronic myocardial ischemia 55 maximal tolerated 55 myoclonus 55 incidence ≥ 55 IOP lowering 55 titrated glipizide plus 55 Carotid endarterectomy 55 Score DAS# 55 systolic dysfunction 55 Neuroticism 55 Oral corticosteroids 55 postural sway 55 diarrhea nausea vomiting 55 ß blockers 55 QTc 55 blood Phe levels 55 bivariate analysis 55 gadolinium enhancing lesions 55 cerebral oxygen saturation 55 glycated hemoglobin HbA1c 55 Heart Failure Therapies 55 Coronary calcium 55 sumatriptan naproxen sodium 55 pulmonary artery pressure 55 cortical activation 55 cerebrovascular events 55 oxygen desaturation 55 AGILECT R 55 acromegalic patients 55 ECOG PS 55 angiotensin II receptor blockers 55 CRQ 55 certolizumab 55 polysomnogram 55 inflammatory biomarkers 55 somatic complaints 55 Phacoemulsification 55 sonographically guided 55 #mg BID [001] 55 nonpharmacologic 55 Intravitreal injections 55 carotid atherosclerosis 55 Albuminuria 55 baseline A1C 55 claudication 55 aspartate aminotransferase 55 transrectal ultrasound guided 55 1mg dose 55 angiography CTA 55 QTcF 55 quetiapine Seroquel 55 R# #mg BID 55 serum lipid 55 MCID 55 tonometry 55 glycated hemoglobin levels 55 Demonstrate Significant 55 QRS duration